PF-00337210
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-00337210, covering 2013-03-19 to 2013-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors [Phase 1]